These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16161313)

  • 1. [Infection of the diabetic foot].
    Jeffcoate W; Game F; Hartemann-Heurtier A
    Journ Annu Diabetol Hotel Dieu; 2005; ():131-41. PubMed ID: 16161313
    [No Abstract]   [Full Text] [Related]  

  • 2. New developments in diagnosing and treating diabetic foot infections.
    Lipsky BA
    Diabetes Metab Res Rev; 2008; 24 Suppl 1():S66-71. PubMed ID: 18395871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and prevalence of methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis in patients with diabetic foot ulcers: focus on the differences between species isolated from individuals with ischemic vs. neuropathic foot ulcers.
    Galkowska H; Podbielska A; Olszewski WL; Stelmach E; Luczak M; Rosinski G; Karnafel W
    Diabetes Res Clin Pract; 2009 May; 84(2):187-93. PubMed ID: 19269053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A role of lokal facilities is topic treatment in a prophylaxis and treatment of infections complications of diabetic foot].
    Khramilin VN
    Khirurgiia (Mosk); 2011; (10):78-81. PubMed ID: 22334910
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibiotic therapy in diabetic foot infection.
    van der Meer JW; Koopmans PP; Lutterman JA
    Diabet Med; 1996; 13 Suppl 1():S48-51. PubMed ID: 8741830
    [No Abstract]   [Full Text] [Related]  

  • 6. New concepts in managing diabetic foot infections.
    Leichter SB; Schaeffer JC; O'Brian JT
    Geriatrics; 1991 May; 46(5):24-30. PubMed ID: 2029973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of a combination of ofloxacin and tinidazole in the management of infectious diabetic foot ulcer.
    Joshi S; Maroli S; Moulick ND; Badhane S; Joshi S; Sthalekar N; Ambavane V; Patil R; Abhyankar M; Dilip P
    J Indian Med Assoc; 2003 May; 101(5):329-32. PubMed ID: 14575233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and healing impact of multidrug-resistant bacteria in diabetic foot ulcers.
    Richard JL; Sotto A; Jourdan N; Combescure C; Vannereau D; Rodier M; Lavigne JP;
    Diabetes Metab; 2008 Sep; 34(4 Pt 1):363-9. PubMed ID: 18632297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on the treatment of diabetic foot infections.
    Kosinski MA; Joseph WS
    Clin Podiatr Med Surg; 2007 Jul; 24(3):383-96, vii. PubMed ID: 17613382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double trouble: infection and ischemia in the diabetic foot.
    Edmonds M
    Int J Low Extrem Wounds; 2009 Jun; 8(2):62-3. PubMed ID: 19443892
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk factors for infection of the diabetic foot with multi-antibiotic resistant microorganisms.
    Kandemir O; Akbay E; Sahin E; Milcan A; Gen R
    J Infect; 2007 May; 54(5):439-45. PubMed ID: 17018235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common pathogens isolated in diabetic foot infection in Bir Hospital.
    Sharma VK; Khadka PB; Joshi A; Sharma R
    Kathmandu Univ Med J (KUMJ); 2006; 4(3):295-301. PubMed ID: 18603922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream.
    Lipsky BA; Holroyd KJ; Zasloff M
    Clin Infect Dis; 2008 Dec; 47(12):1537-45. PubMed ID: 18990064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of yeasts in diabetic foot ulcer infection].
    Missoni EM; Kalenić S; Vukelić M; De Syo D; Belicza M; Kern J; Babić VV
    Acta Med Croatica; 2006; 60(1):43-50. PubMed ID: 16802571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of uncomplicated skin and skin structure infections in the diabetic patient.
    Rich P
    J Drugs Dermatol; 2005; 4(6 Suppl):s26-9. PubMed ID: 16300227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific guidelines for treatment of diabetic foot osteomyelitis.
    Berendt AR; Peters EJ; Bakker K; Embil JM; Eneroth M; Hinchliffe RJ; Jeffcoate WJ; Lipsky BA; Senneville E; Teh J; Valk GD
    Diabetes Metab Res Rev; 2008; 24 Suppl 1():S190-1. PubMed ID: 18442187
    [No Abstract]   [Full Text] [Related]  

  • 17. Foot infection.
    Fowler D; Rayman G
    Diabet Med; 2006 Jul; 23 Suppl 3():18-21. PubMed ID: 16805879
    [No Abstract]   [Full Text] [Related]  

  • 18. High fosfomycin concentrations in bone and peripheral soft tissue in diabetic patients presenting with bacterial foot infection.
    Schintler MV; Traunmüller F; Metzler J; Kreuzwirt G; Spendel S; Mauric O; Popovic M; Scharnagl E; Joukhadar C
    J Antimicrob Chemother; 2009 Sep; 64(3):574-8. PubMed ID: 19578081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of absorbable antibiotic-impregnated calcium sulphate pellets in the management of diabetic foot infections.
    Armstrong DG; Findlow AH; Oyibo SO; Boulton AJ
    Diabet Med; 2001 Nov; 18(11):942-3. PubMed ID: 11703445
    [No Abstract]   [Full Text] [Related]  

  • 20. Empirical therapy for diabetic foot infections: are there clinical clues to guide antibiotic selection?
    Lipsky BA
    Clin Microbiol Infect; 2007 Apr; 13(4):351-3. PubMed ID: 17359317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.